Response to letter regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials".

AuthorsStefan K James, Robert F Storey, Karen S Pieper, Christopher P Cannon, Richard C Becker, Philippe Gabriel Steg, Lars Wallentin, Robert A Harrington,
JournalStroke; a journal of cerebral circulation (Stroke) Vol. 44 Issue 8 Pg. e95-6 (Aug 2013) ISSN: 1524-4628 [Electronic] United States
PMID23800556 (Publication Type: Comment, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Adenosine
  • Acute Coronary Syndrome (drug therapy)
  • Adenosine (analogs & derivatives)
  • Humans
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Purinergic P2Y Receptor Antagonists (therapeutic use)
  • Stroke (drug therapy)
  • Thrombosis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: